Press release
Global Fondaparinux Market Growth, Size, Share, Industry Report and Forecast 2020-2026
The global fondaparinux market is estimated to grow at a CAGR of nearly 7.5% during the forecast period. Significant rise in the prevalence of arthritis is primarily driving the global fondaparinux market. As per the Centers for Disease Control and Prevention (CDC), by 2040, the number of adults aged 18 years and over in the US with doctor-diagnosed arthritis is estimated to rise 49% to 78.4 million (25.9% of the estimated total US adult population), compared to 54.4 million adults in 2013–2015. Additionally, as per the Versus Arthritis, in UK, musculoskeletal conditions including arthritis and back pain affected nearly 18.8 million people in 2017.Request a Free Sample of our Global Fondaparinux Market: https://www.omrglobal.com/request-sample/fondaparinux-market
Osteoarthritis is the most common form of arthritis that are affecting millions of people globally. Globally, over 200 million women suffer from osteoporosis. 1 in 3 postmenopausal women has osteoporosis, which increases with age. Therefore, increasing prevalence of geriatric population is also a major cause for the rising incidences of osteoarthritis. As per the United Nations (UN), by 2050, 1 in 6 people globally will be more than the age of 65, increased from 1 in 11 in 2019. In 2019, 703 million people were aged 65 years or over globally, which is expected to double to 1.5 billion in 2050.
Osteoporosis commonly affects joints in hips, knees, spine, and hands, which results in the increasing number of hip and knee replacements. As per the Canadian Institute for Health Information (CIHI), in 2017-2018, 70,502 knee replacements and 58,492 hip replacements were performed in Canada. This shows a rise of 17.0% and 17.4%, respectively, over the last 5 years. According to the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man (NJR), there were a total of 242,629 cases registered to NJR during 2016/2017. It has shown a significant rise of over 20,000 joint replacement procedures than the previous year. This, in turn, is contributing to the adoption of fondaparinux to prevent deep vein thrombosis (blood clot) after the procedure.
A full Report of Global Fondaparinux Market is Available at: https://www.omrglobal.com/industry-reports/fondaparinux-market
Fondaparinux is used for the treatment of severe blood clots in the lungs or legs. It is often utilizing with another blood thinner drugs (warfarin). If blood clots are untreated, it can travel to the brain, heart, or lungs, causing serious breathing problems, stroke, or heart attack. Fondaparinux is further used for the prevention of blood clots after some procedures with an increased risk of blood clots, including knee and hip replacements, abdominal surgery, and hip fracture. Fondaparinux works similarly like heparin that blocks the activity of some clotting substances in the blood. However, fondaparinux has a longer half-life than heparin and does not interact with platelets. This, in turn, is contributing to the growth of the global fondaparinux market.
Global Fondaparinux Market- Segmentation
By Product Type
• Branded
• Generics
Global Fondaparinux Market– Segment by Region
North America
• United States
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
Company Profiles
• Apicore LLC
• Aurobindo Pharma Ltd.
• Cadila Healthcare Ltd. (CHL)
• Dr Reddy’s Laboratories Ltd.
• GlaxoSmithKline plc
• Italfarmaco S.p.A.
• Mylan N.V.
• Sandoz International GmbH
• ScinoPharm Taiwan, Ltd.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/fondaparinux-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Fondaparinux Market Growth, Size, Share, Industry Report and Forecast 2020-2026 here
News-ID: 2191505 • Views: …
More Releases from ORION MARKET RESEARCH

Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033.
Road Marking Paint Market Overview
The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new…

Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period.
Outboard Boat Market Overview
The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including…

Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033.
Mobile Ticketing Market Overview
The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,…

Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033.
Metal Alloy Market Overview
The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in…
More Releases for Fondaparinux
Fondaparinux Market Expecting Huge Demand in Upcoming Years
The Fondaparinux Market 2025 Report makes available the current and future technical and financial analysis of the industry. It is one of the most comprehensive and important additions to the USD Analytics Market archive of market research studies. It offers detailed research and analysis of key aspects of the global Fondaparinux market. This global report explores the key factors affecting the growth of the dynamic Fondaparinux market, including the demand-supply…
Global Fondaparinux Sodium Market Imapct of AI and Automation
Fondaparinux Sodium Market Impact of AI and Automation
The global Fondaparinux Sodium market was valued at approximately USD 1.2 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of around 7.5% through the forecast period. This growth trajectory is driven by increasing demand for advanced anticoagulant therapies and a rising prevalence of thromboembolic disorders. The market's expansion is further supported by the growing adoption of…
Global Fondaparinux Market Growth, Size, Report & Forecast to 2020-2026
The global fondaparinux market is estimated to grow at a CAGR of nearly 7.5% during the forecast period. Significant rise in the prevalence of arthritis is primarily driving the global fondaparinux market. As per the Centers for Disease Control and Prevention (CDC), by 2040, the number of adults aged 18 years and over in the US with doctor-diagnosed arthritis is estimated to rise 49% to 78.4 million (25.9% of the…
Fondaparinux Industry : Market | Size | Analysis | Share | Outlook to 2025
Fondaparinux Industry Report has been prepared based on an in-depth market analysis with inputs from industry experts.
The report provides key statistics on the market status of the Fondaparinux Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
Global Fondaparinux Market focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost,…
Global Fondaparinux Market 2016 - Reliable Biopharmaceutical, Aspen, Apotex, GSK …
Global Fondaparinux market Report offers decisive insights into the overall Fondaparinux industry along with the market dimensions and evaluation for the duration 2016 to 2021. The forenamed research study covers extensive analysis of various Fondaparinux industry segments based on the type of applications, type of product Components and services, and different geographical regions.
Fondaparinux market, an injectable blood thinner that fights clots in the legs (deep vein thrombosis) and lungs…
Global Fondaparinux Market 2017 - Reliable Biopharmaceutical, Aspen, Apotex, GSK …
Global Fondaparinux market Report offers decisive insights into the overall Fondaparinux industry along with the market dimensions and evaluation for the duration 2017 to 2022. The forenamed research study covers extensive analysis of various Fondaparinux industry segments based on the type of applications, type of product Components and services, and different geographical regions.
Fondaparinux, an injectable blood thinner that fights clots in the legs (deep vein thrombosis) and lungs (pulmonary…